Rheumatology Highlights Report

 

Rheumatology Highlights Report

Do you have 15 minutes? A patient cancelled an
appointment or you finished a meeting early? Give us
15 minutes and we will give you the world of rheumatology.

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

The Rheumatology Highlights Report is designed for the busy clinician. It is designed to provide highlights from key scientific presentations and/or abstracts presented at ACR and EULAR annual meetings. Clinical experts attending these meetings have selected the most significant data to report. Each activity includes a 15-minute presentation with supporting materials and commentary on the clinical implications of the data. This series offer two methods of participation: on your computer or mobile device.

Target Audience

Rheumatologists are the primary audience for these activities, as well as other health care professionals managing patients with rheumatic disease, including primary care practitioners, internists, and cardiologists.

Highlights from the 2011 EULAR Annual Meeting
Highlights from the 2011 ACR Annual Meeting

Highlights from 2011 ACR Annual Meeting

Gregg J. Silverman, MD Systemic Lupus Erythematosus: Pathology, Diagnosis, and Treatment
Gregg J. Silverman, MD

Estimated Time: 30 minutes
Release Date:  February 7, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  February 7, 2013
Specialties:  Rheumatology / Immunology

Leonard H. Calabrese, DO Update on Safety of Biologics
Leonard H. Calabrese, DO

Estimated Time: 15 minutes
Release Date:  February 2, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  February 2, 2013
Specialties:  Rheumatology / Immunology

Leonard H. Calabrese, DO Vasculitis: Pathology, Diagnosis, and Treatment
Leonard H. Calabrese, DO

Estimated Time: 15 minutes
Release Date:  January 20, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  January 20, 2013
Specialties:  Rheumatology / Immunology

Jonathan Kay, MD Osteoarthritis & Miscellaneous Rheumatic Disorders
Jonathan Kay, MD

Estimated Time: 15 minutes
Release Date:  January 20, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  January 20, 2013
Specialties:  Rheumatology / Immunology

Philip Mease, MD Advances in Psoriatic Arthritis
Philip Mease, MD

Estimated Time: 15 minutes
Release Date:  January 12, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  January 12, 2013
Specialties:  Rheumatology / Immunology

Vibeke Strand, MD Small Molecular Immunomodulators
Vibeke Strand, MD

Estimated Time: 15 minutes
Release Date:  January 10, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  January 10, 2013
Specialties:  Rheumatology / Immunology

N. Lawrence Edwards, MD Crystalline Arthritis
N. Lawrence Edwards, MD

Estimated Time: 15 minutes
Release Date:  January 9, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  January 9, 2013
Specialties:  Rheumatology / Immunology

Eric Ruderman, MD Ankylosing Spondylitis Highlights
Eric Ruderman, MD

Estimated Time: 15 minutes
Release Date:  January 9, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  January 9, 2013
Specialties:  Rheumatology / Immunology

Elaine Husni, MD Update on Cardiovascular Effects in Patients with Rheumatoid Arthritis
Elaine Husni, MD

Estimated Time: 15 minutes
Release Date:  January 5, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  January 5, 2013
Specialties:  Rheumatology / Immunology

Allan Gibofsky, MD Therapy of RA with Non-Biologic DMARDs
Allan Gibofsky, MD

Estimated Time: 15 minutes
Release Date:  January 5, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  January 5, 2013
Specialties:  Rheumatology / Immunology

Arthur Kavanaugh, MD New and Emerging Biologics
Arthur Kavanaugh, MD

Estimated Time: 15 minutes
Release Date:  January 4, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  January 4, 2013
Specialties:  Rheumatology / Immunology

William Rigby, MD B and T Cell-Directed Therapy for Rheumatoid Arthritis
William Rigby, MD

Estimated Time: 15 minutes
Release Date:  January 4, 2012
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  January 4, 2013
Specialties:  Rheumatology / Immunology

William Rigby, MD Advances in Basic Science
William Rigby, MD

Estimated Time: 15 minutes
Release Date:  December 29, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  December 29, 2012
Specialties:  Rheumatology / Immunology

Chad Deal, MD Osteoporosis
Chad Deal, MD

Estimated Time: 15 minutes
Release Date:  December 29, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  December 29, 2012
Specialties:  Rheumatology / Immunology

Roy Fleischmann, MD Disease Measures in Rheumatoid Arthritis
Roy Fleischmann, MD, MACR

Estimated Time: 15 minutes
Release Date:  December 28, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  December 28, 2012
Specialties:  Rheumatology / Immunology

Marc Cohen, MD Advances in Efficacy and Safety of TNF Inhibitors
Marc Cohen, MD

Estimated Time: 15 minutes
Release Date:  December 28, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  December 28, 2012
Specialties:  Rheumatology / Immunology

Highlights from 2011 EULAR Annual Meeting

Update on Rheumatoid Arthritis and Cardiovascular Disease
M. Elaine Husni, MD, MPH

Estimated Time: 30 minutes
Release Date: October 10, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: October 10, 2012
Specialties: Rheumatology / Immunology

Advances in Psoriatic Arthritis
Philip Mease, MD

Estimated Time: 15 minutes
Release Date: August 22, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 22, 2012
Specialties: Rheumatology / Immunology

Ankylosing Spondylitis
Christopher Ritchlin, MD

Estimated Time: 15 minutes
Release Date: August 22, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 22, 2012
Specialties: Rheumatology / Immunology

Rheumatoid Arthritis: Clinical Aspects, Outcomes, and Measures
Roy Fleischmann, MD

Estimated Time: 30 minutes
Release Date: August 22, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 22, 2012
Specialties: Rheumatology / Immunology

Vasculitis: Pathology, Diagnosis, and Treatment
Leonard H. Calabrese, DO

Estimated Time: 15 minutes
Release Date: August 22, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 22, 2012
Specialties: Rheumatology / Immunology

Advances in Basic Science
Leonard H. Calabrese, DO

Estimated Time: 15 minutes
Release Date: August 22, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 22, 2012
Specialties: Rheumatology / Immunology

Miscellaneous Rheumatic Disorders
Jonathan Kay, MD

Estimated Time: 30 minutes
Release Date: August 22, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 22, 2012
Specialties: Rheumatology / Immunology

Systemic Lupus Erythematosus: Pathology, Diagnosis, and Treatment
Gregg Silverman, MD

Estimated Time: 15 minutes
Release Date: August 22, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 22, 2012
Specialties: Rheumatology / Immunology

Update on Safety of Biologics
Leonard H. Calabrese, DO

Estimated Time: 15 minutes
Release Date: August 17, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 17, 2012
Specialties: Rheumatology / Immunology

Rheumatoid Arthritis: T Cell and B Cell-Targeting Agents
William Rigby, MD

Estimated Time: 15 minutes
Release Date: August 17, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 17, 2012
Specialties: Rheumatology / Immunology

Advances in Gout and Other Crystal Diseases
Brian Mandell, MD, PhD

Estimated Time: 30 minutes
Release Date: August 12, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 12, 2012
Specialties: Rheumatology / Immunology

Small Molecular Immunomodulators
Vibeke Strand, MD

Estimated Time: 15 minutes
Release Date: August 12, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 12, 2012
Specialties: Rheumatology / Immunology

Advances in Metabolic Bone Disease
Johannes W.J. Bijlsma, MD, PhD

Estimated Time: 15 minutes
Release Date: August 12, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date: August 12, 2012
Specialties: Rheumatology / Immunology

New and Emerging Biologics
Arthur Kavanaugh, MD

Estimated Time: 15 minutes
Release Date:  August 11, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  August 11, 2012
Specialties: Rheumatology / Immunology

RA: Nonbiologic Therapy, Including DMARDs
Allan Gibofsky, MD, JD, FACP, FCLM

Estimated Time: 15 minutes
Release Date:  August 11, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  August 11, 2012
Specialties: Rheumatology / Immunology

Advances in Efficacy and Safety of TNF Inhibitors
Marc Cohen, MD

Estimated Time: 15 minutes
Release Date:  August 11, 2011
Type: Webcast

Technical Requirements: Flash Player
Expiration Date:  August 11, 2012
Specialties: Rheumatology / Immunology

Series Objectives

  1. Describe current rends in management of autoimmune and inflammatory disease including issues such as monitoring disease activiity, damage treating to target and relate to key laboratory and imaging modalities.
  2. Summarize results from biologic studies and discuss potential implications for clinical practice.
  3. Synthesize data from clinical trials using biologic or nonbiologic therapies and assess their impact on clinical practice.
  4. Discuss new and emerging biologic therapies, especially T-cell and B-cell targeting therapy as they apply to RA and SLE and Vasculitis.
  5. Review data on the efficacy and side effects of biologic therapies in RA-associated diseases.
  6. Describe the potential for serious infections associated with biologic therapies and explain steps for recognizing and diagnosing the events.
  7. Describe the molecular basis of intracellular signaling pathways (eg, JAK-STAT and other kinase pathways) as they relate to immune physiology in health and disease.
  8. Describe advances in key rheumatic disorders including systemic lupus erythematosus, vasculitis, ankylosing spondylitis, psoriatic arthritis, osteoarthritis and gout.
  9. Describe advances in the management of metabolic bone disease.
  10. Describe cardiovascular morbidity and its relationship to RA, SLE and vasculitis pathogenesis and treatment.

Activity Director

Leonard H. Calabrese, DO
Professor of Medicine
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Vice Chairman, Department of Rheumatic & Immunologic Diseases
R.J. Fasenmyer Chair of Clinical Immunology
Orthopaedic & Rheumatologic Institute
Cleveland Clinic
Cleveland, OH